Telemus Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $10.6M | Buy |
19,921
+942
| +5% | +$456K | 0.87% | 27 |
|
|
2023
Q3 | $9.61M | Buy |
18,979
+158
| +0.8% | +$84.2K | 0.89% | 25 |
|
|
2023
Q2 | $9.82M | Sell |
18,821
-363
| -2% | -$196K | 0.83% | 27 |
|
|
2023
Q1 | $11.1M | Buy |
19,184
+87
| +0.5% | +$49K | 0.97% | 26 |
|
|
2022
Q4 | $10.2M | Buy |
19,097
+62
| +0.3% | +$32.9K | 0.93% | 25 |
|
|
2022
Q3 | $9.65M | Buy |
19,035
+6
| +0% | +$3.36K | 0.99% | 24 |
|
|
2022
Q2 | $10.3M | Sell |
19,029
-4,527
| -19% | -$2.49M | 1% | 22 |
|
|
2022
Q1 | $13.9M | Sell |
23,556
-100
| -0.4% | -$57.4K | 1.21% | 17 |
|
|
2021
Q4 | $15.8M | Sell |
23,656
-379
| -2% | -$237K | 1.27% | 16 |
|
|
2021
Q3 | $13.7M | Sell |
24,035
-1,802
| -7% | -$989K | 1.16% | 21 |
|
|
2021
Q2 | $13M | Sell |
25,837
-54
| -0.2% | -$25.5K | 0.94% | 29 |
|
|
2021
Q1 | $12M | Sell |
25,891
-2,580
| -9% | -$1.23M | 0.83% | 27 |
|
|
2020
Q4 | $13.3M | Sell |
28,471
-808
| -3% | -$379K | 0.99% | 25 |
|
|
2020
Q3 | $13.7M | Sell |
29,279
-273
| -0.9% | -$113K | 1.01% | 24 |
|
|
2020
Q2 | $11.3M | Sell |
29,552
-1,106
| -4% | -$371K | 0.89% | 29 |
|
|
2020
Q1 | $10.7M | Sell |
30,658
-727
| -2% | -$229K | 0.88% | 30 |
|
|
2019
Q4 | $10.2M | Sell |
31,385
-662
| -2% | -$201K | 0.79% | 30 |
|
|
2019
Q3 | $9.33M | Sell |
32,047
-230
| -0.7% | -$65.9K | 0.75% | 31 |
|
|
2019
Q2 | $8.66M | Sell |
32,277
-1,807
| -5% | -$498K | 0.77% | 32 |
|
|
2019
Q1 | $9.33M | Sell |
34,084
-4,989
| -13% | -$1.24M | 0.71% | 35 |
|
|
2018
Q4 | $8.74M | Buy |
39,073
+3,110
| +9% | +$730K | 0.71% | 28 |
|
|
2018
Q3 | $8.78M | Buy |
35,963
+433
| +1% | +$99.6K | 0.66% | 30 |
|
|
2018
Q2 | $7.36M | Buy |
35,530
+527
| +2% | +$112K | 0.57% | 36 |
|
|
2018
Q1 | $7.23M | Buy |
35,003
+824
| +2% | +$173K | 0.58% | 34 |
|
|
2017
Q4 | $6.49M | Buy |
34,179
+1,109
| +3% | +$212K | 0.5% | 41 |
|
|
2017
Q3 | $6.26M | Sell |
33,070
-1,681
| -5% | -$304K | 0.71% | 26 |
|
|
2017
Q2 | $6.06M | Buy |
34,751
+1,066
| +3% | +$179K | 0.61% | 27 |
|
|
2017
Q1 | $5.17M | Sell |
33,685
-2,000
| -6% | -$306K | 0.54% | 36 |
|
|
2016
Q4 | $5.04M | Buy |
35,685
+9,443
| +36% | +$1.39M | 0.68% | 33 |
|
|
2016
Q3 | $4.17M | Buy |
26,242
+1,625
| +7% | +$250K | 0.47% | 37 |
|
|
2016
Q2 | $3.64M | Sell |
24,617
-295
| -1% | -$43.5K | 0.45% | 47 |
|
|
2016
Q1 | $3.53M | Buy |
+24,912
| New | +$3.34M | 0.59% | 38 |
|
Other funds holding TMO
Telemus Capital's TMO Position: Q4 2023 in Review
Telemus Capital increased its Thermo Fisher Scientific (TMO) stake by 5% in Q4 2023, buying an estimated $456K and bringing the position to 19,921 shares worth $10.6M. The position accounts for 0.87% of the portfolio, ranked #27.
Telemus Capital first reported a position in TMO in Q1 2016 and has held it in 32 quarters since. The position peaked at $15.8M in Q4 2021. 2,487 funds tracked by Wall St. Rank hold TMO as of Q4 2023.
- Telemus Capital held 19,921 shares of Thermo Fisher Scientific worth $10.6M as of Q4 2023.
- Telemus Capital bought 942 Thermo Fisher Scientific shares in Q4 2023, an estimated $456K.
- Thermo Fisher Scientific made up 0.87% of Telemus Capital's portfolio in Q4 2023, its #27 holding.
- Telemus Capital first reported a position in Thermo Fisher Scientific in Q1 2016 and has held it in 32 quarters since.
- Telemus Capital's Thermo Fisher Scientific position peaked at $15.8M in Q4 2021.
- 2,487 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.
Based on Telemus Capital's 13F filing for Q4 2023, filed 1 Feb 2024.